Literature DB >> 188871

Cerebrospinal fluid immunoglobulin quotients, kappa/lambda ratios, and viral antibody titres in neurological disease.

P J Roberts-Thomson, M M Esiri, A C Young, I C Maclennan.   

Abstract

A description has been given of cerebrospinal fluid (CSF) immunoglobulins in 355 patients with demyelinating, infectious, neuropathic, and other neurological disorders. An increase in the CSF IgG/albumin quotient was observed in 19/36 (53%) cases of definite multiple sclerosis (MS), in 13/47 (28%) cases of probable or possible MS, in 6/9 (67%) cases of proven herpes simplex viral encephalitis (HSVE), in 3/4 (75%) cases of neurosyphilis, in 1/1 case of subacute sclerosing panencephalitis (SSPE), in 2/9 )22%) cases of other central nervous system infections, and in 2/12 (17%) cases of polyneuritis when compared with a group of 236 patients having other neurological disorders. In constrast, a relative increase in the CSF IgA of IgM was seen only in some of the patients with central nervous system infections. It was also found that the quotient CSF/serum IgG, expressed as a percentage of the CSF/serum albumin, was better in distinguishing patients with definite or suspected MS from those with other neurological disorders than the quotients IgG/albumin or IgG/total protein. The CSF K/lambda ratio and the CSF and serum complement-fixing antibody titre to measles and herpes simplex virus were measured in many of the patients. In general, abnormalities of these measurements were associated with raised IgG/albumin quotients. However, in eight patients with definite or suspected MS, a normal IgG/albumin quotient was found with abnormal CSF K/lambda ratios (6 cases) or abnormal CSF titres of measles antibody (7 cases). In addition, two patients, with HSVE had normal IgG/albumin ratios but detectable herpes antibody in the CSF. These findings suggest that the measurement of the relative concentration of CSF immunoglobulin in combination with the K/lambda ratio and antibody titre to various viruses may supplement each other in the endeavour to detect central nervous system immunglobulin sysnthesis in neurological diseases.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 188871      PMCID: PMC476313          DOI: 10.1136/jcp.29.12.1105

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  21 in total

1.  Measles antibodies in multiple sclerosis.

Authors:  J M ADAMS; D T IMAGAWA
Journal:  Proc Soc Exp Biol Med       Date:  1962-12

2.  Neurological diseases with elevation of cerebrospinal fluid gamma globulin: a critical review.

Authors:  D H HARTER; M D YAHR; E A KABAT
Journal:  Trans Am Neurol Assoc       Date:  1962

3.  A simple ultraviolet spectrophotometric method for the determination of protein.

Authors:  W J WADDELL
Journal:  J Lab Clin Med       Date:  1956-08

4.  An immunochemical study of the proteins in cerebrospinal fluid.

Authors:  F D ROSENTHAL; J F SOOTHILL
Journal:  J Neurol Neurosurg Psychiatry       Date:  1962-05       Impact factor: 10.154

5.  A study of the crystalline albumin, gamma globulin and total protein in the cerebrospinal fluid of 100 cases of multiple sclerosis and in other diseases.

Authors:  E A KABAT; D A FREEDMAN
Journal:  Am J Med Sci       Date:  1950-01       Impact factor: 2.378

6.  Measles virus antibodies in multiple sclerosis. Comparison of antibody titers in cerebrospinal fluid and serum.

Authors:  E Norrby; H Link; J E Olsson
Journal:  Arch Neurol       Date:  1974-04

7.  Immunoglobulin abnormalities in the Guillain-Barré syndrome.

Authors:  H Link
Journal:  J Neurol Sci       Date:  1973-01       Impact factor: 3.181

8.  Electrophoretic morphology of gamma globulins in cerebrospinal fluid of multiple sclerosis and other diseases of the nervous system.

Authors:  E C Laterre; A Callewaert; J F Heremans; Z Sfaello
Journal:  Neurology       Date:  1970-10       Impact factor: 9.910

9.  The protein composition of the cerebrospinal fluid in acute necrotizing encephalitis. An agar gel electrophoretic and immunoelectrophoretic study.

Authors:  R A van Welsum; H J van der Helm
Journal:  Neurology       Date:  1970-10       Impact factor: 9.910

10.  Electrophoretic distribution of kappa and lambda immunoglobulin light chain determinants in serum and cerebrospinal fluid in multiple sclerosis.

Authors:  O Zettervall; H Link
Journal:  Clin Exp Immunol       Date:  1970-09       Impact factor: 4.330

View more
  7 in total

1.  Total protein is an effective loading control for cerebrospinal fluid western blots.

Authors:  Mahlon A Collins; Jiyan An; Danielle Peller; Robert Bowser
Journal:  J Neurosci Methods       Date:  2015-05-22       Impact factor: 2.390

Review 2.  Innate Immune Mechanisms and Herpes Simplex Virus Infection and Disease.

Authors:  Evelyn A Kurt-Jones; Megan H Orzalli; David M Knipe
Journal:  Adv Anat Embryol Cell Biol       Date:  2017       Impact factor: 1.231

3.  Disproportionate elevation of the immunoglobulin G1 concentration in cerebrospinal fluids of patients with multiple sclerosis.

Authors:  W P Kaschka; L Theilkaes; K Eickhoff; F Skvaril
Journal:  Infect Immun       Date:  1979-12       Impact factor: 3.441

4.  Measles antibodies and kappa-lambda light chain distribution in immunoglobulins of patients affected with multiple sclerosis.

Authors:  F Bollengier; A Mahler
Journal:  J Neurol       Date:  1979-03-22       Impact factor: 4.849

5.  Intrathecal immunoglobulin synthesis in cerebral malaria.

Authors:  H M Chapel; D A Warrell; S Looareesuwan; N J White; R E Phillips; M J Warrell; V Supawanta; S Tharavanij
Journal:  Clin Exp Immunol       Date:  1987-03       Impact factor: 4.330

6.  Cerebrospinal fluid in multiple sclerosis: relationships between immunoglobulins, leucocytes and clinical features.

Authors:  R W Walker; E J Thompson; W I McDonald
Journal:  J Neurol       Date:  1985       Impact factor: 4.849

7.  Detection of oligoclonal IgG kappa and IgG lambda bands in cerebrospinal fluid and serum with Hevylite™ antibodies. comparison with the free light chain oligoclonal pattern.

Authors:  David Zeman; Pavel Hradílek; Zdeněk Svagera; Eva Mojžíšková; Ivana Woznicová; Olga Zapletalová
Journal:  Fluids Barriers CNS       Date:  2012-02-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.